{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:36:46Z","timestamp":1775234206922,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.052","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:18:55Z","timestamp":1559121535000},"page":"3840-3848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001\u20132014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain)"],"prefix":"10.1016","volume":"37","author":[{"given":"Pedro P.","family":"Espa\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane","family":"Uranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mar\u00eda","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Aramburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyre","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ayarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Patricia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Zalacain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2019.05.052_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2019.05.052_b0010","doi-asserted-by":"crossref","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL; AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratal\u00e0 J, Chang FY, Charles PG, Diaz AA, Dom\u00ednguez J, Ehara N, Endeman H, Falc\u00f3 V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Marekovi\u0107 I, Masi\u00e1 M, Matta MA, Mir\u00f3 \u00d2, Murdoch DR, Nuermberger E, Paolini R, Perell\u00f3 R, Snijders D, Ple\u010dko V, Sord\u00e9 R, Str\u00e5lin K, van der Eerden MM, Vila-Corcoles A, Watt JP . Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4):e60273.","DOI":"10.1371\/journal.pone.0060273"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.052_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.052_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-14-128","article-title":"Pneumococcal pneumonia: differences according to blood culture results","volume":"14","author":"Capelastegui","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.vaccine.2019.05.052_b0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/315760","article-title":"Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries","volume":"182","author":"Kalin","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.052_b0030","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/IAI.67.5.2327-2333.1999","article-title":"Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae","volume":"67","author":"Kim","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.052_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2014.03.001","article-title":"Pneumococcal vaccination in Europe: schedule adherence","volume":"36","author":"Gervaix","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2019.05.052_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.vaccine.2019.05.052_b0045","unstructured":"Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep. 2012 Jun 1;61(21):394-5."},{"key":"10.1016\/j.vaccine.2019.05.052_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2013.12.013","article-title":"Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections","volume":"25","author":"Grau","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.05.052_b0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.arbres.2010.06.014","article-title":"Sociedad espa\u00f1ola de neumolog\u00eda y cirug\u00eda tor\u00e1cica. community acquired pneumonia. new guidelines of the spanish society of chest diseases and thoracic surgery (SEPAR)]","volume":"46","author":"Men\u00e9ndez","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.vaccine.2019.05.052_b0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.05.052_b0065","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/JCM.01156-16","article-title":"Single-step multiplex PCR assay for determining 92 pneumococcal serotypes","volume":"54","author":"Marimon","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.052_b0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of risk with death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.052_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active bacterial core surveillance\/emerging infections program network. sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.052_b0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.052_b0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.052_b0090","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.052_b0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/21645515.2015.1102811","article-title":"Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: should we expect herd protection of adults through infants' vaccination?","volume":"12","author":"Azzari","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.05.052_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/1469-0691.12518","article-title":"The role of vaccination in preventing pneumococcal disease in adults","volume":"20","author":"Aliberti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.05.052_b0105","series-title":"Abstract 5051. European Respiratory Society (ERS) Annual Congress 2013, Barcelona, Spain, 7\u201311 September 2013","article-title":"Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010\u20132012)","author":"Torres","year":"2013"},{"key":"10.1016\/j.vaccine.2019.05.052_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043619","article-title":"Epidemiology of invasive pneumococcal disease in older people in Spain (2007\u20132009): Implications for future vaccination strategies","volume":"7","author":"Ardanuy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.05.052_b0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/thoraxjnl-2015-206780","article-title":"Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and\/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease","volume":"70","author":"Torres","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.052_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.052_b0125","first-page":"142","article-title":"Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions","volume":"30","author":"Gonz\u00e1lez-Romo","year":"2017","journal-title":"2017 Update. Rev Esp Quimioter"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.052_b0130","first-page":"19385","article-title":"Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia","author":"Burgos","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.052_b0135","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1183\/09031936.00144712","article-title":"Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults","volume":"42","author":"Bewick","year":"2013","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.052_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2016.1263409","article-title":"A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009\u20132016)","volume":"13","author":"Moreira","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.052_b0145","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.05.052_b0150","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.vaccine.2017.01.032","article-title":"For the CAPiTA study group. exploratory efficacy endpoints in the community acquired penumonia immunization trial in adults (CAPITA)","volume":"35","author":"Webber","year":"2017","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2019.05.052_b0155","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.vaccine.2014.03.054","article-title":"Working Group for surveillance of the pneumococcal disease in navarre. reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013","volume":"32","author":"Guevara","year":"2014","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2019.05.052_b0160","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2016.03.052","article-title":"CAPNETZ Study Group. impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay","volume":"34","author":"Pletz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.052_b0165","unstructured":"Descriptive epidemiology of invasive pneumococcal disease in Bizkaia 2017, published in 2018. <http:\/\/www.osakidetza.euskadi.eus\/r85-pkvigi05\/es\/contenidos\/informacion\/memorias_epidemiologica\/es_def\/index.shtml>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:06Z","timestamp":1759401246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":33,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19306899"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001\u20132014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}